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Introduction
============

The use of cocaine as an illicit drug surged in the United States of America between 2002 and 2007 and currently, it is the second most abused drug after cannabis and alcohol \[[@REF1]-[@REF3]\]. Among the adults, the annual prevalence of cocaine use was 1.5%, while some states reported the prevalence of 5.5% to 5.8% in the age group of 18 to 25 years. The United Nations Office on Drugs and Crime and the European Monitoring Centre for Drugs and Drug Addiction has reported an increase of cocaine use in particular parts of the world \[[@REF4]\]. The burden of health care due to cocaine dependence was reported high in the recent studies \[[@REF4]\]. Around 23.9 million people aged 12 years and above were reported using illicit drugs in 2012 according to data from the National Survey on Drug Use and Health \[[@REF5]\]. A recent study from a community hospital found 2.3% people being cocaine positive during drug screening in the age group of 65 years and older. In the USA, the areas of primary concern are the one rampaged with poverty and poor education \[[@REF6]\]

One report from the emergency department notes in the Detroit area in 2002 showed cocaine use of around 182/100,000 of the population \[[@REF7]\]. It is not merely a problem of one country; rather it has turned into a global issue \[[@REF1]\]. The cocaine use leads to the spectrum of multisystem derangements ranging from mild intoxication to severe complications like acute myocardial infarction, seizures and acute ischemic stroke \[[@REF8]\]. Compared to the corresponding peer groups in the general population, cocaine users tend to have four to eight times higher mortality \[[@REF9]-[@REF10]\]. Use of cocaine is presumed to be one of the major risk factors for cerebrovascular disease, including stroke. Acute ischemic stroke (AIS) is labeled as the third leading cause of disability-adjusted life years \[[@REF10]\].

Previous studies have reported a 19% increase in the incidence of strokes due to cocaine use in the last two decades \[[@REF11]\]. The rise in cocaine-associated morbidity and mortality posed it as a major public health concern \[[@REF11]-[@REF12]\]. Impacts on health care economies due to stroke-related disability is devastating owing to medical cost, rehabilitation cost and cost due to loss of workforce. A direct or indirect burden of around \$68.9 billion was imposed on the US healthcare owing to strokes in 2009, a major part of which was comprised of strokes as a result of illicit drugs use \[[@REF2]\]. We aim to evaluate various factors associated with acute ischemic strokes (AIS) risk and to develop the management strategies to mitigate mortality rates within cocaine-induced stroke population.

Materials and methods
=====================

Data source

We utilized the discharge data from the National Inpatient Sample (NIS) of the Healthcare Cost and Utilization Project (HCUP) as a source. The NIS is an all-payer dataset that includes around eight million (around 20% of the stratified sample) inpatient admissions and discharges from almost 1050 USA hospitals, excluding long term care and rehabilitation facilities. The NIS data set is unweighted and it results in the weighted estimate of the total discharge number of the US population when we apply the discharge weight to the unweighted data. We excluded the data of missing information such as age, gender, discharge condition or primary diagnosis. We used the International Classification of Diseases, Ninth Revision, Clinical Modification (ICD-9-CM) to identify admissions with the primary diagnosis of AIS. Since NIS is publicly available de-identified database from Agency for Healthcare Research and Quality (AHRQ), it does not require an approval from institutional review board (IRB). More details on the dataset content and methods of collections are accessible on the HCUP website \[[@REF13]\].

Patient selection

We looked into the NIS database of the year 2014 to identify all patients with AIS with ICD-9-CM codes (433.01, 433.11, 433.21, 433.31, 433.81, 433.91, 434.01, 434.11, 434.91 and 436). Current use of cocaine (dependence or abuse) was identiﬁed using the ICD-9-CM codes 304.20 (cocaine dependence, unspecified), 305.62 (non-dependent cocaine use, episodic), 305.61 (non-dependent cocaine use, continuous), 304.21 (cocaine dependence, continuous) and 304.22 (cocaine dependence, episodic) \[[@REF14]\] (Appendix).

Variables

Demographic variables examined in this study included age group (1-17, 18-44, 45-64, 65-84 years and \> 85), gender (male or female), race (white, Hispanic, Asian or Pacific Islander, Native American and other) and payer source (Medicare, Medicaid, private pay, self-pay, no charge and other). Based on existing literature, we searched and defined AIS risk factors using diagnosis codes from ICD-9-CM mentioned in the appendix.

Statistical analysis

Statistical Package for the Social Science, version 22.0 (SPSS V.22.0, IBM Corp., Armonk, NY, USA) was used for all the statistical analysis. The incidence of AIS hospitalization among cocaine users and nonusers were determined by searching all available diagnosis fields for the diagnosis of AIS. Further age stratification was performed of the population into groups of 1-17, 18-44, 45-64, 65-84 years and \> 85 years. Pearson's chi-square test was used for categorical data and the independent sample T-test was used for continuous data. We used a multivariate logistic regression model to assess the AIS outcomes of cocaine use. Standard weights from HCUP were utilized to get the national weighted estimates of inpatient admissions. We defined p-value less than 0.05 (p \< 0.005) as the statistical significance.

Results
=======

Baseline characteristics of acute ischemic strokes cohort

We identified the total of 584,115 patients with AIS by using the discharge data from NIS of the year 2014. We further stratified cohorts into a cocaine use (N=1135) and non-cocaine use (N=582980). The AIS with cocaine group consisted of higher number of older patients (\> 85 years) (25.6% versus 18.7%, p \<0.001), females (52.4% versus 51.0%, p \<0.001) and whites (89.2% versus 70.3%, p \<0.001). Cardiovascular incidences that were higher in the cocaine cohort versus non-cocaine cohort included valvular disorders (13.2% versus 9.7%, p \<0.001), venous thromboembolism (3.5% versus 2.6%, p \<0.03), vasculitis (0.9% versus 0.4%, p \<0.003), and sudden cardiac death (0.4% versus 0.2%, p \<0.02). The incidence of epilepsy was higher in cocaine cohort (10.1% versus 7.4 %, p \<0.001). The incidence of major depression was higher in cocaine cohort (13.2% versus 10.7%, p \<0.007). The incidences of other risk factors for AIS such as atherosclerosis, cardiac circulatory anomalies, hypertension (complicated and uncomplicated), elevated cholesterol, diabetes, transient ischemic attack (TIA), paralysis, family history of stroke, deficiency anemia, coagulopathy, disorders of fluid and electrolytes were significantly higher in the non-cocaine cohort (Table [1](#TAB1){ref-type="table"}).

###### Baseline characteristics of hospitalized acute ischemic stroke patients without versus with cocaine.

Significant P-values ≤ 0.05 at 95% confidence interval, variables were Agency for Healthcare Research and Quality (AHRQ) comorbidity measures.

Abbreviations: AIS= acute ischemic strokes, SNF= skilled nursing facility, INF= intermediate nursing facility, RA= rheumatoid arthritis, CVD= collagen vascular diseases.

  ------------------------------------------------------------------------------------------------------------------------- ------------------ --------------- -----------
  Variables                                                                                                                 AIS + NO Cocaine   AIS + Cocaine   P-value\*
  Unweighted admissions                                                                                                     116596             227              
  Weighted admissions                                                                                                       582980             1135             
  Age in years at admission                                                                                                                                    
  Mean Age ± SD                                                                                                             69.87±15.01        72.91±14.29     \<0.001
  1-17                                                                                                                      0.5%               0.0%            \<0.001
  18-44                                                                                                                     4.6%               3.5%            \<0.001
  45-64                                                                                                                     28.6%              23.8%           \<0.001
  65-84                                                                                                                     47.5%              47.1%           \<0.001
  \>85                                                                                                                      18.7%              25.6%           \<0.001
  Died during hospitalization                                                                                                                                  
  Did not die                                                                                                               93.1%              89.9%           \<0.001
  Died                                                                                                                      6.9%               10.1%           \<0.001
  Disposition of Patient                                                                                                                                       
  Routine                                                                                                                   32.3%              22.5%           \<0.001
  To Short-term Hospitals                                                                                                   3.4%               11.3%           \<0.001
  Other (SNF, ICF, Another facility)                                                                                        43.4%              37.0%           \<0.001
  Home Health Care                                                                                                          13.2%              18.1%           \<0.001
  Against Medical Advice (AMA)                                                                                              0.7%               0.9%            \<0.001
  Died                                                                                                                      6.9%               10.1%           \<0.001
  Discharged alive, destinations unknown                                                                                    0.1%               0.0%            \<0.001
  Elective Vs. Non-elective Admissions                                                                                                                         
  Non-elective                                                                                                              93.6%              98.2%           \<0.001
  Elective                                                                                                                  6.4%               1.8%            \<0.001
  Indicator of Sex                                                                                                                                             
  Male                                                                                                                      49.0%              47.6%           0.346
  Female                                                                                                                    51.0%              52.4%           0.346
  Primary Expected Payer                                                                                                                                       
  Medicare                                                                                                                  65.7%              72.1%           \<0.001
  Medicaid                                                                                                                  9.0%               9.3%            \<0.001
  Private including HMO                                                                                                     18.7%              16.4%           \<0.001
  Self - Pay                                                                                                                4.1%               1.3%            \<0.001
  No charge                                                                                                                 0.4%               0.0%            \<0.001
  Other                                                                                                                     2.1%               0.9%            \<0.001
  Race                                                                                                                                                         
  White                                                                                                                     70.3%              89.2%           \<0.001
  Black                                                                                                                     16.8%              6.3%            \<0.001
  Hispanic                                                                                                                  7.3%               4.1%            \<0.001
  Asian or Pacific Islander                                                                                                 2.4%               0.0%            \<0.001
  Native American                                                                                                           0.5%               0.0%            \<0.001
  Other                                                                                                                     2.7%               0.5%            \<0.001
  Co --morbidities                                                                                                                                             
  RA/CVD                                                                                                                    2.7%               4.0%            0.009
  Atherosclerosis                                                                                                           28.7%              25.6%           0.020
  Acute Myocardial Infarction                                                                                               4.6%               4.8%            0.667
  Arrhythmia                                                                                                                0.3%               0.4%            0.204
  Sudden Cardiac Death                                                                                                      0.2%               0.4%            0.024
  Cardiac Circulatory Anomalies                                                                                             3.0%               1.3%            \<0.001
  Heart Valve Disorders                                                                                                     11.2%              14.1%           0.002
  Vasculitis                                                                                                                0.4%               0.9%            0.003
  Hypertension                                                                                                              79.8%              72.2%           \<0.001
  Elevated BP without Hypertension                                                                                          0.2%               0.0%            0.106
  Elevated Cholesterol                                                                                                      54.7%              42.3%           \<0.001
  Venous Thromboembolism                                                                                                    2.6%               3.5%            0.039
  Viral Infection                                                                                                           0.6%               0.0%            0.007
  Pulmonary Circulation Disorders                                                                                           4.1%               6.2%            \<0.001
  Paralysis                                                                                                                 10.0%              7.5%            0.005
  Transient Ischemic Attacks                                                                                                1.1%               0.0%            \<0.001
  Family History of Stroke                                                                                                  2.3%               0.4%            \<0.001
  Acute but ill-defined Cerebrovascular Disease                                                                             0.3%               0.0%            0.091
  Epilepsy                                                                                                                  7.4%               10.1%           \<0.001
  Other neurological disorders                                                                                              5.5%               2.6%            \<0.001
  Depression                                                                                                                10.7%              13.2%           0.007
  Psychoses                                                                                                                 3.9%               2.6%            0.034
  Alcohol abuse                                                                                                             4.5%               3.1%            0.021
  Drug Abuse                                                                                                                3.1%               1.8%            0.011
  Deficiency anemia                                                                                                         14.7%              12.8%           0.063
  Coagulopathy                                                                                                              5.5%               4.0%            0.025
  Metastatic cancer                                                                                                         1.9%               3.1%            0.005
  Solid Tumor without Metastasis                                                                                            1.9%               3.1%            0.005
  Diabetes, uncomplicated                                                                                                   29.8%              26.0%           0.005
  Oral contraceptive use                                                                                                    0.1%               0.4%            0.009
  Renal failure                                                                                                             16.3%              11.5%           \<0.001
  Rhabdomyolysis                                                                                                            1.6%               0.4%            \<0.001
  Fluid and electrolyte Disorders                                                                                           27.6%              20.3%           \<0.001
  Liver Disease                                                                                                             1.7%               1.3%            0.334
  Obesity                                                                                                                   11.4%              10.6%           0.356
  ------------------------------------------------------------------------------------------------------------------------- ------------------ --------------- -----------

Multivariable risk factors for acute ischemic strokes hospitalization

Table [2](#TAB2){ref-type="table"} shows different variables that were used in the multivariate logistic regression model to identify AIS risk factors requiring hospitalization. We found cocaine use to be the major risk factor for hospitalization. In-hospital mortality was also observed to be higher in cocaine cohort with the 95% confidence interval (CI) 1.1-1.9 (OR= 1.4, 95% CI= 1.1-1.9, p \<0.003). A disposition to short-term hospitals (OR= 2.6, 95% CI= 2.1-3.3, p \<0.001) and home healthcare (OR= 1.5, 95% CI= 1.2-1.9, p \<0.001) was also significantly higher after adjusting for confounders. Personal history of sudden cardiac arrests (OR= 7.9, 95% CI= 3.1-20.1, p \<0.001) were significantly associated with cocaine use which could be another manifestation due to potential vasospasm \[[@REF8]\]. Venous thromboembolism was observed to be linked with cocaine use (OR= 1.5, 95% CI= 1.0-2.1, p \< 0.01), but less severely than vasculitis (OR= 3.0, 95% CI= 1.6-5.8, p\<0.001) (Table [2](#TAB2){ref-type="table"}).

###### Predictors of hospitalization in acute ischemic strokes (AIS) cocaine cohort versus acute ischemic strokes (AIS) on cocaine cohort by multivariate logistic regression.

Significant P-value ≤ 0.05 at 95% and ≤ 0.01 at 99% confidence interval, variables are Agency for Healthcare Research and Quality (AHRQ) co-morbidity measures.

Abbreviations: SNF= skilled nursing facility, INF= intermediate nursing facility, RA= rheumatoid arthritis CVD= collagen vascular diseases, CI= confidence interval, HMO= Health Maintenance Organization.

  ------------------------------------------------------- ------------ ---------------- ---------------- -----------
  Variables                                               Odds Ratio   95% CI           99% CI           P-value\*
  Weekend Admissions                                                                                     
  Monday-Friday                                           Referent     Referent         Referent          
  Saturday-Sunday                                         0.952        0.827 - 1.096    0.791 - 1.145    0.492
  Disposition of Patient                                                                                 
  Routine                                                 Referent     Referent         Referent          
  To Short-term Hospitals                                 2.691        2.143 - 3.380    1.995 - 3.630    \<0.001
  Other (SNF, ICF, Another Facility)                      0.970        0.809 - 1.164    0.764 - 1.233    0.745
  Home Health Care                                        1.574        1.291 - 1.920    1.213 - 2.043    \<0.001
  Against Medical Advice (AMA)                            1.370        0.719 - 2.610    0.587 - 3.196    0.338
  Died                                                    1.485        1.147 - 1.922    1.058 - 2.084    0.003
  Elective versus Non-elective Admissions                                                                
  Non-elective                                            0.374        0.238 - 0.588    0.206 - 0.678    \<0.001
  Elective                                                Referent     Referent         Referent          
  Indicator of Sex                                                                                       
  Male                                                    Referent     Referent         Referent          
  Female                                                  0.966        0.849 - 1.098    0.816 - 1.144    0.597
  Length of stay (cleaned)                                                                               
  1 to 3 days                                             Referent     Referent         Referent          
  4 to 6 days                                             0.776        0.661 - 0.910    0.629 - 0.957    0.002
  7 to 9 days                                             1.074        0.876 - 1.316    0.822 - 1.403    0.493
  10 to 12 days                                           1.159        0.886 - 1.515    0.815 - 1.649    0.281
  ≥13 days                                                1.252        0.988 - 1.588    0.917 - 1.711    0.063
  Primary Expected Payer                                                                                 
  Medicare                                                1.311        0.694 - 2.476    0.568 - 3.024    0.405
  Medicaid                                                1.757        0.904 - 3.415    0.733 - 4.208    0.097
  Private including HMO                                   1.048        0.548 - 2.002    0.447 - 2.454    0.888
  Self - Pay                                              0.635        0.262 - 1.544    0.198 - 2.040    0.317
  Other                                                   Referent     Referent         Referent          
  Race                                                                                                   
  White                                                   9.310        3.854 - 22.488   2.921 - 29.668   \<0.001
  Black                                                   3.883        1.563 - 9.648    1.174 - 12.842   0.003
  Hispanic                                                6.792        2.688 - 17.158   2.009 - 22.958   \<0.001
  Other                                                   Referent     Referent         Referent          
  Median Household Income Quartile on Patient's ZIP                                                      
  \$ 1 - \$ 39, 999                                       0.610        0.489 - 0.761    0.456 - 0.815    \<0.001
  \$ 40, 000 - \$ 50,999                                  0.734        0.615 - 0.876    0.582 - 0.926    \<0.001
  \$ 51, 000 - \$ 65, 999                                 0.977        0.843 - 1.133    0.805 - 1.186    0.759
  \$ 66, 000 +                                            Referent     Referent         Referent          
  Bed Size of Hospital                                                                                   
  Small                                                   1.426        1.225 - 1.662    1.167 - 1.743    \<0.001
  Medium                                                  1.158        1.001 - 1.340    0.957 - 1.402    0.048
  Large                                                   Referent     Referent         Referent          
  Location and Teaching Status of Hospital                                                               
  Rural                                                   1.573        1.244 - 1.989    1.156 - 2.141    \<0.001
  Urban - non teaching                                    1.061        0.909 - 1.238    0.866 - 1.299    0.452
  Urban - teaching                                        Referent     Referent         Referent          
  Control/ownership of Hospital                                                                          
  Government, non-federal                                 0.198        0.077 - 0.505    0.058 - 0.678    \<0.001
  Private, non profit                                     1.306        0.944 - 1.805    0.853 - 1.999    0.107
  Private, invest -own                                    Referent     Referent         Referent          
  Co --morbidities^\#^                                                                                   
  Musculoskeletal                                                                                        
  RA/CVD                                                  1.464        1.039 - 2.063    0.933 - 2.297    0.029
  Connective Tissue Disorder                              0.800        0.392-1.632      0.313- 2.042     0.539
  Cardiovascular                                                                                         
  Congestive Heart Failure                                1.156        0.971 - 1.376    0.919 - 1.453    0.104
  Atherosclerosis                                         0.789        0.681 - 0.913    0.651 - 0.956    \<0.001
  AMI                                                     0.841        0.622 - 1.137    0.566 - 1.249    0.259
  Arrhythmia                                              2.744        1.093 - 6.886    0.819 - 9.194    0.032
  Sudden Cardiac Death                                    7.950        3.135 - 20.163   2.340 - 27.013   \<0.001
  SupraVentricular Premature Beats                        2.478        1.009 - 6.085    0.761 - 8.070    0.048
  Cardiac Circulatory Anomalies                           0.280        0.149 - 0.525    0.122 - 0.640    \<0.001
  Cardiomyopathy                                          1.085        0.832 - 1.415    0.766 - 1.538    0.546
  Tachycardia                                             0.867        0.357 - 2.107    0.270 - 2.785    0.753
  Heart Valve Disorders                                   0.679        0.363 - 1.270    0.298 - 1.546    0.226
  Peripheral Vascular Disorders                           1.200        0.989 - 1.456    0.931 - 1.547    0.065
  Vasculitis                                              3.077        1.609 - 5.886    1.312- 7.217     \<0.001
  Hypertension                                            0.982        0.846 - 1.139    0.807- 1.194     0.807
  Elevated Cholesterol                                    0.642        0.564 - 0.731    0.541 - 0.761    \<0.001
  Aortic and Peripheral Arterial Embolism or Thrombosis   0.682        0.278 - 1.670    0.210 - 2.214    0.402
  Venous Thromboembolism                                  1.518        1.097 - 2.100    0.991- 2.326     0.012
  Respiratory                                                                                            
  Chronic Pulmonary Disease                               0.895        0.752 - 1.064    0.712 - 1.123    0.207
  Pneumothorax (pleurisy)                                 0.944        0.677 - 1.316    0.610 - 1.460    0.733
  Pulmonary Circulation Disorders                         1.133        0.852 - 1.507    0.779 - 1.649    0.391
  Neurological                                                                                           
  Paralysis                                               0.695        0.540 - 0.895    0.499 - 0.969    0.005
  Family History of Stroke                                0.270        0.112 - 0.654    0.085 - 0.864    0.004
  Meningitis                                              1.951        0.786 - 4.842    0.591 - 6.443    0.150
  Migraine                                                1.157        0.833 - 1.607    0.752 - 1.782    0.383
  Epilepsy                                                1.563        1.266 - 1.930    1.185 - 2.062    \<0.001
  Other Neurological Disorders                            0.469        0.320 - 0.687    0.284 - 0.775    \<0.001
  Psychiatry                                                                                             
  Depression                                              1.486        1.243 - 1.777    1.175 - 1.880    \<0.001
  Psychoses                                               0.832        0.575 - 1.205    0.512 - 1.354    0.331
  Alcohol abuse                                           0.761        0.535 - 1.082    0.479 - 1.208    0.128
  Drug Abuse                                              0.964        0.603 - 1.541    0.521 - 1.786    0.879
  Hemato-oncological                                                                                     
  Deficiency Anemia                                       1.061        0.878 - 1.281    0.827 - 1.360    0.542
  Chronic Blood Loss Anemia                               1.071        0.437 - 2.626    0.330 - 3.480    0.880
  Coagulopathy                                            0.811        0.593 - 1.109    0.538 - 1.224    0.190
  Weight Loss                                             1.308        0.986 - 1.736    0.902 - 1.898    0.063
  Metastatic Cancer                                       1.052        0.722 - 1.533    0.642 - 1.725    0.791
  Solid Tumor without Metastasis                          1.109        0.764 - 1.610    0.680 - 1.810    0.585
  Lymphoma                                                0.553        0.228 - 1.343    0.173 - 1.774    0.191
  Endocrinological                                                                                       
  Diabetes, Uncomplicated                                 0.981        0.847 - 1.136    0.809 - 1.190    0.799
  Diabetes with Chronic Complications                     1.191        0.926 - 1.531    0.856 - 1.656    0.173
  Oral Contraceptive Use                                  8.277        3.247 - 21.097   2.420 - 28.308   \<0.001
  Hypothyroidism                                          0.749        0.617 - 0.909    0.581 - 0.966    \<0.003
  Renal                                                                                                  
  Acute Renal Failure                                     1.539        1.278 - 1.852    1.205 - 1.964    \<0.001
  Rhabdomyolysis                                          0.224        0.092 - 0.544    0.070 - 0.718    \<0.001
  Fluid and Electrolyte Disorders                         0.612        0.518 - 0.725    0.491 - 0.764    \<0.001
  Gastrointestinal                                                                                       
  Liver Disease                                           0.913        0.540 - 1.544    0.458 - 1.821    0.734
  Obesity                                                 1.255        1.027 - 1.533    0.965 - 1.633    0.026
  ------------------------------------------------------- ------------ ---------------- ---------------- -----------

Gender comparison of cocaine-associated mortality

Table [3](#TAB3){ref-type="table"} shows the gender comparison in co-morbidities associated mortality in the cocaine cohort. Higher overall mortality due to cardiac (except arrhythmia and supraventricular premature beats) causes and acute renal failure was observed in males, whereas females had increased overall mortality owing to elevated cholesterol, heart valve disorders, vasculitis, epilepsy, arrhythmia, supraventricular premature beats (SVPB), peripheral arterial thromboembolism and heart valve disorders. A similar rate of mortalities between males and females was found due to events of elevated blood pressure without hypertension (which could be owing to incidental cocaine intake) and acute cerebrovascular disease.

###### Gender comparison in comorbidities associated mortality in acute ischemic stroke (AIS) cocaine cohort.

  ----------------------------------------------- -------- --------- ---------
  Comorbidities and predictors of mortality       Died     P-value   
  Male                                            Female             
  Cocaine use                                     0.2%     0.3%      0.160
  Cardiomyopathy                                  11.9%    9.0%      \<0.001
  Acute myocardial infarction                     15.5%    13.7%     \<0.001
  Atherosclerosis                                 36.0%    27.4%     \<0.001
  Acute renal failure                             40.7%    31.3%     \<0.001
  Arrhythmia                                      0.2%     0.4%      \<0.001
  Supraventricular Premature Beats                0.1%     0.2%      \<0.001
  Sudden cardiac death                            0.6%     0.3%      \<0.001
  Cardiac and circulatory anomalies               2.2%     1.5%      \<0.001
  Transient ischemic attacks                      0.6%     0.5%      \<0.001
  Tachycardia                                     1.9%     1.8%      \<0.001
  Elevated BP without hypertension                0.1%     0.1%      \<0.001
  Pneumothorax and pleurisy                       12.3%    9.8%      \<0.001
  Bronchiolitis obliterans organizing pneumonia   0.1%     0.1%      \<0.001
  Rhabdomyolysis                                  4.3%     3.0%      \<0.001
  Elevated cholesterol and lipids                 35.1%    35.3%     \<0.001
  Meningitis                                      1.2%     0.7%      \<0.001
  Migraine                                        0.6%     1.3%      \<0.001
  Sickle cell disease                             0.1%     0.2%      \<0.001
  Oral contraceptive use                          0.0%     0.1%      0.472
  Viral infection                                 1.0%     0.6%      \<0.001
  Heart valve disorder                            11.3%    12.2%     \<0.001
  Vasculitis                                      0.4%     0.6%      \<0.001
  Connective tissue disorder                      0.2%     1.1%      0.107
  Aortic, peripheral arterial thromboembolism     1.6%     2.0%      \<0.001
  Acute vascular insufficiency of intestine       0.9%     0.6%      \<0.001
  Epilepsy                                        11.9%    12.2%     \<0.001
  Family History Stroke (cerebrovascular)         0.6%     0.7%      \<0.001
  Acute but ill-defined cerebrovascular disease   0.4%     0.4%      \<0.001
  Drug induced headache                           0.0%     0.0%      0.071
  ----------------------------------------------- -------- --------- ---------

Multivariable predictors of mortality

Table [4](#TAB4){ref-type="table"} shows the comparison of various comorbidity related mortality odds between cocaine and non-cocaine cohorts. Mortality odds owing to liver disease, metastatic cancer, cardiomyopathy, acute myocardial infarction, and epilepsy were increased in both non-cocaine and cocaine cohort. Whereas, increased odds of mortality in the non-cocaine cohort were observed due to coagulopathy, disorders of fluid and electrolyte, obesity, weight loss, solid tumor without metastasis, elevated cholesterol, pneumothorax and pleurisy and congestive heart failure. Effect on mortality due to other variables is shown in Table [4](#TAB4){ref-type="table"}.

###### Multivariate predictors of the mortality in acute ischemic stroke patients without cocaine use versus with cocaine use

Significant P-values ≤ 0.05 at 95% and  ≤ 0.01 at 99% confidence interval, variables are Agency for Healthcare Research and Quality (AHRQ) co-morbidity measures.

  ------------------------------------------- ------------ ------------------------- ----------- ------------ ------------------------- ----------- --------- ---------
  Variables                                   No Cocaine   Cocaine                                                                                            
                                              Odds ratio   99% Confidence Interval   P-value\*   Odds ratio   99% Confidence Interval   P-value\*             
  Co -- morbidities^\#^                                                                                                                                       
  Deficiency anemias                          0.899        0.866                     0.933       \<0.001      1.809                     0.622       5.258     0.153
  Congestive heart failure                    1.540        1.487                     1.596       \<0.001      0.506                     0.174       1.471     0.100
  Chronic pulmonary disease                   1.125        1.085                     1.166       \<0.001      1.078                     0.431       2.694     0.833
  Coagulopathy                                1.720        1.644                     1.800       \<0.001      0.378                     0.042       3.428     0.256
  Depression                                  0.751        0.713                     0.791       \<0.001      0.191                     0.048       0.753     0.002
  Diabetes, uncomplicated                     0.891        0.862                     0.921       \<0.001      0.364                     0.156       0.850     0.002
  Hypertension                                0.725        0.701                     0.749       \<0.001      0.302                     0.119       0.765     0.001
  Hypothyroidism                              1.031        0.990                     1.074       0.052        1.521                     0.527       4.395     0.308
  Liver disease                               1.210        1.107                     1.322       \<0.001      12.608                    1.255       126.656   0.005
  Fluid and electrolyte disorders             1.582        1.534                     1.632       \<0.001      1.046                     0.430       2.546     0.896
  Metastatic cancer                           1.921        1.787                     2.065       \<0.001      4.895                     1.318       18.184    0.002
  Other neurological disorders                1.129        1.074                     1.187       \<0.001      0.461                     0.064       3.314     0.312
  Obesity                                     0.754        0.717                     0.793       \<0.001      0.694                     0.204       2.356     0.441
  Paralysis                                   1.494        1.437                     1.553       \<0.001      0.929                     0.269       3.207     0.879
  Peripheral vascular disorders               1.145        1.097                     1.196       \<0.001      3.405                     1.296       8.947     0.001
  Pulmonary circulation disorders             1.268        1.195                     1.345       \<0.001      0.295                     0.075       1.157     0.021
  Renal failure                               1.077        1.037                     1.119       \<0.001      0.775                     0.222       2.702     0.599
  Solid tumor without metastasis              1.279        1.174                     1.394       \<0.001      0.534                     0.075       3.785     0.409
  Weight loss                                 1.263        1.206                     1.323       \<0.001      0.959                     0.296       3.107     0.927
  Cardiomyopathy                              1.076        1.024                     1.132       \<0.001      3.008                     0.844       10.722    0.026
  Acute myocardial infarction                 2.431        2.323                     2.544       \<0.001      7.820                     2.173       28.138    \<0.001
  Atherosclerosis                             1.071        1.037                     1.106       \<0.001      0.844                     0.371       1.918     0.594
  Tachycardia                                 1.950        1.746                     2.179       \<0.001      2.133                     0.131       34.728    0.484
  Elevated Cholesterol and lipid              0.558        0.541                     0.575       \<0.001      0.815                     0.325       2.042     0.566
  Pneumothorax and pleurisy                   1.622        1.542                     1.706       \<0.001      0.263                     0.048       1.449     0.044
  Epilepsy                                    1.479        1.412                     1.550       \<0.001      9.322                     3.721       23.355    \<0.001
  ------------------------------------------- ------------ ------------------------- ----------- ------------ ------------------------- ----------- --------- ---------

Discussion
==========

The current study found 96.5% of the AIS cocaine cohort was of the age group above 45 years with age ranging from 18 years to 85 years and above. In the age group of 85 years and above, the prevalence of AIS within the cocaine group surpassed the non-cocaine users. A plausible explanation could be that the cumulative effect of traditional risk factors, along with the long-term accumulation of chronic cocaine effect makes such population more vulnerable towards the risk of stroke \[[@REF2]\]. The frequency of hospitalization was high among the urban hospitals set up.

A majority of the AIS patients visited the private, nonprofit hospitals. Among these, the odds of ones with cocaine use visiting the government, non-federal hospital were significantly low. The nature of the admission was nonelective understandable for most of the AIS cohort and within this cohort; it was significantly higher among the cocaine users. It could be because most of the patients are chronic cocaine abusers rather than acute. This finding is also justifiable from the older age group pattern of the study subject which is prone to the cumulative effect of the cocaine rather than acute features \[[@REF2]\]. Odds of hospitalization among the whites were higher compared to the blacks and Hispanics in AIS cocaine cohort versus AIS non-cocaine cohort.

The mortality was found higher in blacks as compared to whites and Hispanic (21.4% versus 8.6% versus 11.1%, P=0.004 respectively). Analyzing the disposition of the patients, the short-term hospitals stay and death was significantly higher among the cocaine users. The associated higher comorbidities could be a possible explanation for such disposition in cocaine users as compared to the non-cocaine group. This finding is a serious concern because such patients could lead to a significant burden on the healthcare infrastructure. With increasing median household income, the frequency of hospitalization significantly increased among the cocaine users suggesting that the ones with low income and living in a poverty have a lower risk of using cocaine. Another reason could be that socioeconomic status is the poor predictor of the stroke among the cocaine users. Despite having high median household income among the cocaine users, their hospitalization was significantly elevated in the small and medium-sized hospitals. This could be due to the acute nature of the condition among these subjects, requiring urgent admission to any of the nearby facility.

The family history of the stroke was higher among the non-cocaine users as compared to the cocaine users suggesting that the usual mechanism of stroke development is not applicable to the cocaine user. Cocaine users quite commonly bear the traditional cardiovascular risk factors \[[@REF2]\]. Sudden cardiac death, paroxysmal supraventricular tachycardia (PSVT), vasculitis and venous thromboembolism take higher odds of hospitalization.

Odds of hospitalization due to the paralysis were significantly higher among the non-cocaine users while seizures were high among the cocaine users. The frequency of depression was significantly higher among the cocaine abusers signifying the high morbidity among such populations. The incidence of diabetes and congestive heart failure (CHF) was severely high among the cocaine users, while the frequency of hypertension was quite similar to the other studies \[[@REF2]\].

There was a significantly higher rate of valvular heart disease and venous thromboembolism among the cocaine users, suggesting of emboli as the major risk for stroke among these populations as compared to the non-cocaine users \[[@REF15]-[@REF17]\]. We reported the higher mortality among the cocaine users as compared to the non-cocaine users \[[@REF18]\].

The older age of our study population could be a plausible reason, as studies with the young demographic and mild strokes have reported overall low mortality \[[@REF19]\]. When we looked for the multivariate predictors of death in the AIS patients without cocaine use and with cocaine use, we found that epilepsy, peripheral vascular disorders, acute myocardial infarction, cardiomyopathy, tachycardia, metastatic cancer and liver diseases were associated with higher odds of mortality among cocaine users as compared to the non-cocaine users.

Hypertension and diabetes were not found to be associated with the excess mortality in an AIS cocaine cohort compared to the AIS non-cocaine cohort. Several postulated mechanisms for cocaine-induced ischemic stroke has been suggested \[[@REF20]-[@REF23]\]. Among these, the cardioembolic ischemic strokes and cardiac deaths due to chronic cocaine use have been proposed to be prominent \[[@REF17], [@REF24]\]. 

Study limitations

This study has undeniable limitations because of the NIS database which might have coding errors in terms of determining the diagnosis, comorbidities, and complications. Due to the inherent nature of large hospital's database, it may over or underestimate AIS, cocaine use, comorbidities and other clinically relevant variables based on ICD-9 CM codes. This study also lacked variables such as medications and other treatment options related to AIS.

This database does not mention about the cause of death, so we cannot differentiate between in-hospital events and cause of death. It might be possible to have a selection bias in this study because of a retrospective population study. Due to large data size and getting national estimates using discharge weight as provided by NIS database, we could overcome these limitations. 

Conclusions
===========

To our knowledge, this is one of the very few studies demonstrating the effects of cocaine use on stroke using the nationally representative data source. Our results displaying the amplitude of the mortality in an AIS-cocaine cohort raised the question whether to consider cocaine as a risk factor in all AIS patients or not. Further research is warranted to evaluate the pathogenesis and health care burden due to cocaine-induced stroke.
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Table [5](#TAB5){ref-type="table"} has the list of ICD-9-CM codes for suspected risk factors of AIS, comorbidities, in-hospital procedures and outcomes.

###### International Classification of Disease, Ninth Revision (ICD-9) codes and the Clinical Classifications Software (CCS) codes used to identify co-morbidities, in-hospital procedures and complications.

Abbreviations: ICD‐9‐CM= International Classification of Diseases, Ninth Revision, Clinical Modification; CCS= Clinical Classification Software.

  ------------------------------------------------------------------- ---------- ---------------------------------------------------------------------------------------------
  Risk Factors/ Co-morbidity                                          Source     Codes
  Acute ischemic stroke                                               ICD-9      433.01, 433.10, 433.11, 433.21, 433.31, 433.81, 433.91, 434.00, 434.01, 434.11, 434.91, 436
  Cocaine                                                             ICD - 9    304.20, 304.21, 304.22, 305.60  305.61, 305.62
  Acute myocardial infarction                                         CCS        100
  Peri-; endo-; and myocarditis, cardiomyopathy                       CCS        97
  Sudden cardiac death                                                ICD - 9    V12.53
  Arrhythmias                                                         ICD - 9    427.9
  Supraventricular premature beats                                    ICD - 9    427.61
  Tachycardia, unspecified                                            ICD - 9    785.0
  Elevated blood pressure reading without diagnosis of hypertension   ICD - 9    796.2
  Rhabdomyolysis                                                      ICD - 9    728.88
  Acute and unspecified renal failure                                 CCS        157
  Bronchiolitis Obliterans organizing pneumonia                       ICD - 9    516.8
  Pleurisy; pneumothorax; pulmonary collapse                          CCS        130
  Epilepsy                                                            CCS        83
  Drug induced headache, not elsewhere classified                     ICD - 9    339.3
  Family Hx Stroke (cerebrovascular)                                  ICD - 9    V17.1
  Acute vascular insufficiency of intestine                           ICD -- 9   557.0
  Aortic and peripheral arterial embolism or thrombosis               CCS        116
  Unspecified venous complication                                     ICD -- 9   671.9
  Venous thrombosis and embolism                                      ICD - 9    V12.51
  Connective tissue diseases                                          CCS        210
  Vasculitis                                                          ICD - 9    447.6; 446.0--446.9
  Meningitis                                                          CCS        76
  Cardiac and circulatory anomalies                                   CCS        213
  Elevated cholesterol and lipids                                     CCS        53
  Migraine                                                            CCS        84
  Sickle cell disease                                                 CCS        61
  Viral infection                                                     CCS        7
  Heart valve disorder                                                CCS        96
  Atherosclerosis                                                     CCS        114
  Acute but ill-defined cerebrovascular disease                       CCS        109
  Transient ischemic attack                                           CCS        112
  Oral contraceptive use                                              CCS        176
  ------------------------------------------------------------------- ---------- ---------------------------------------------------------------------------------------------
